These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7047163)

  • 41. Lipid A and liposomes containing lipid A as antigens and adjuvants.
    Alving CR; Rao M
    Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-hapten response in vitro. Affinity differences in precursors of anti-hapten antibody-producing cells.
    Pasanen VJ; Virolainen M
    Eur J Immunol; 1971 Nov; 1(5):406-8. PubMed ID: 4945641
    [No Abstract]   [Full Text] [Related]  

  • 43. The mode of action of immunological adjuvants. I. A new method to assess the adjuvant effect of substances as represented by mycobacterial adjuvants.
    Tanaka A; Ishibashi T; Koashi O; Koga T; Sugiyama K
    Jpn J Exp Med; 1975 Jun; 45(3):139-46. PubMed ID: 809606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemagglutination induced by lipopolysaccharides and lipid A.
    Kirikae T; Inada K; Hirata M; Yoshida M; Galanos C; Lüderitz O
    Microbiol Immunol; 1986; 30(3):269-74. PubMed ID: 3523165
    [No Abstract]   [Full Text] [Related]  

  • 45. Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal antihapten antibodies of various isotypes.
    Brüggemann M; Rajewsky K
    Cell Immunol; 1982 Aug; 71(2):365-73. PubMed ID: 6754102
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. II. The response to sheep erythrocytes.
    Ghaffar A; James K
    Immunology; 1973 Mar; 24(3):455-65. PubMed ID: 4574575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carrier inhibition in the in vitor response to hapten-erythrocyte conjugate.
    Schwarze G; Pünter J
    Eur J Immunol; 1973 Nov; 3(11):742-4. PubMed ID: 4589171
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro immunity to TNP and penicillin: specific inhibition with hapten-conjugated isologous red cells.
    Naor D; Mishell R
    J Immunol; 1972 Jan; 108(1):246-52. PubMed ID: 4551578
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunogenicity of liposomal model membranes sensitized with dinitrophenylated phosphatidylethanolamine derivatives containing different length spacers.
    Dancey GF; Isakson PC; Kinsky SC
    J Immunol; 1979 Feb; 122(2):638-42. PubMed ID: 84030
    [No Abstract]   [Full Text] [Related]  

  • 50. Immune responses to hapten--lipopolysaccharide conjugates. 1. Modulation of in vivo antibody responses to the polysaccharide.
    Skelly RR; Munkenbeck P; Morrison DC
    Cell Immunol; 1980 Jan; 49(1):99-109. PubMed ID: 6153159
    [No Abstract]   [Full Text] [Related]  

  • 51. An alternative procedure for the preparation of immunogenic liposomal model membranes.
    Kinsky SC; Loader JE; Benson AL
    J Immunol Methods; 1983 Dec; 65(3):295-306. PubMed ID: 6418820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of a water-in-oil emulsion on humoral immunity.
    Bokhout BA; Bianchi AT; van der Heijden PJ; Scholten JW; Stok W
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):161-8. PubMed ID: 2431828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic lipopeptides incorporated in liposomes: in vitro stimulation of the proliferation of murine splenocytes and in vivo induction of an immune response against a peptide antigen.
    Fernandes I; Frisch B; Muller S; Schuber F
    Mol Immunol; 1997 Jun; 34(8-9):569-76. PubMed ID: 9393959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural studies on the immunodominant group of lipid A from lipopolysaccharide of Yersinia pseudotuberculosis.
    Gorbach VI; Krasikova IN; Lukyanov PA; Razmakhnina OY; Solov'eva TF; Ovodov YS
    Eur J Biochem; 1979 Jul; 98(1):83-6. PubMed ID: 89032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A.
    Dijkstra J; Mellors JW; Ryan JL
    Infect Immun; 1989 Nov; 57(11):3357-63. PubMed ID: 2807528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibodies to liposomes, phospholipids and phosphate esters.
    Alving CR
    Chem Phys Lipids; 1986; 40(2-4):303-14. PubMed ID: 3742674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of backbone structures and stereospecificities of lipid A-subunit analogues on their biological activities.
    Matsuura M; Kojima Y; Homma JY; Kumazawa Y; Yamamoto A; Kiso M; Hasegawa A
    J Biochem; 1986 May; 99(5):1377-84. PubMed ID: 3486867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological activities of chemically synthesized partial structure analogues of lipid A.
    Matsuura M; Yamamoto A; Kojima Y; Homma JY; Kiso M; Hasegawa A
    J Biochem; 1985 Nov; 98(5):1229-37. PubMed ID: 4086478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acyclic analogues of lipid A: synthesis and biological activities.
    Bulusu MA; Waldstätten P; Hildebrandt J; Schütze E; Schulz G
    J Med Chem; 1992 Sep; 35(19):3463-9. PubMed ID: 1404227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of Tn, sialyl Tn and HIV-1-derived peptide antigen conjugates having a lipid A analog as an immunoadjuvant for synthetic vaccines.
    Miyajima K; Nekado T; Ikeda K; Achiwa K
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1676-82. PubMed ID: 9845951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.